Cardicell Ltd. is a privately held company, focusing on creating advanced,
innovative and cost-effective devices in the field of cardiology. The Company is firmly established with a professional R & D department including internationally renowned experts in ECG and related fields.
Cardicell is offering sophisticated concepts, blazing new trails in self-diagnosis
development.
Vision and competence drive research and development across
our company. Our prime objective is to create reliable medical accessories
which can monitor and identify a wide range of clinical conditions.
These accessories will enable people all over the world to perform a
preliminary "self-diagnosis" test, shortening the time interval between the
first appearance of a clinical condition and the first aid alert or consultation.
On a more long-term basis, Cardicell's vision is to join the international effort
to decrease mortality and morbidity around the world. We strongly believe that
our biggest asset is the intellectual capital and experience of our skilled and talented team, which comprises 12 in-house employees and consultants.
Our team includes Mr. Igor Landau - former Aventis chairman & CEO, and
Dr. Shlomi Matetzky who is a leading cardiologist at 'Sheba' Hospital, Israel.
The team is headed by Dr. Lior Berkner, the CEO of Cardicell. |
|
Our Mission
Cardicell is determined to become a leader in our field, increasing the efficiency
of its medical self-diagnosis methods and devices. Our mission is to enable
instant detection and treatment of heart pathologies, using an accurate and
reliable device.
Moreover, in order to increase usability and accessibility, we have designed
devices which are easy to operate and highly affordable. We will continuously
improve our professional abilities, supporting a key tenet of our mission - to
strive without reserve for the greatest possible quality in our products.
Cardicell targets the entire adult population, patients at high risk, first aid
companies, insurance companies and organizations with health infrastructures.
Given the implications of undetected heart attacks, adopting a leading detection
system can make the difference between life and death.
|
|
|
|
